Medication for attention deficit-hyperactivity disorder and criminality - Wikidata - awgldk - TriplyDB

Medication for attention deficit-hyperactivity disorder and criminality

Medication for attention deficit-hyperactivity disorder and criminality

http://www.wikidata.org/entity/Q24619697

about

Effect of treatment modality on long-term outcomes in attention-deficit/hyperactivity disorder: a systematic review Underdiagnosis of Attention-Deficit/Hyperactivity Disorder in Adult Patients Ethical aspects of registry-based research in the Nordic countries A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations The association of ADHD symptoms to self-harm behaviours: a systematic PRISMA review The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders Clinical practice: Adult attention deficit-hyperactivity disorder Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients Selective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort Study Varenicline and risk of psychiatric conditions, suicidal behaviour, criminal offending, and transport accidents and offences: population based cohort study Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands.Treatment of psychosis in prisons and violent recidivism.Evaluating beneficial drug effects in a non-interventional setting: a review of effectiveness studies based on Swedish Prescribed Drug Register data.Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case.Predictive validity of parent- and self-rated ADHD symptoms in adolescence on adverse socioeconomic and health outcomes.Towards Precision Addiction Treatment: New Findings in Co-morbid Substance Use and Attention-Deficit Hyperactivity Disorders.Stimulant ADHD medication and risk for substance abuse.Antipsychotics, mood stabilisers, and risk of violent crime Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial ADHD & Pharmacotherapy: Past, Present and Future: A Review of the Changing Landscape of Drug Therapy for Attention Deficit Hyperactivity Disorder Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: an integrated analysis of the complete database of multicenter placebo-controlled trials.Adult attention deficit hyperactivity disorder and violence in the population of England: does comorbidity matter?Mindfulness based cognitive therapy versus treatment as usual in adults with attention deficit hyperactivity disorder (ADHD).Prevalence of ADHD in nonpsychotic adult psychiatric care (ADPSYC): A multinational cross-sectional study in Europe.Co-morbid psychiatric disorders among incarcerated ADHD populations: a meta-analysis Psychiatric disorders and violent reoffending: a national cohort study of convicted prisoners in Sweden Diet and ADHD, Reviewing the Evidence: A Systematic Review of Meta-Analyses of Double-Blind Placebo-Controlled Trials Evaluating the Efficacy of Diet Interventions on the Behavior of Children with ADHD.Distribution and Within-Family Specificity of Quantitative Autistic Traits in Patients with Neurofibromatosis Type I.A national epidemiological study investigating risk factors for police interrogation and false confession among juveniles and young persons Top-Down Dysregulation-From ADHD to Emotional Instability Understanding the treatment of attention deficit hyperactivity disorder in newly diagnosed adult patients in general practice: a UK database study Ethical, Legal and Social Issues Surrounding Research on Genetic Contributions to Anti-Social Behavior.Association Between Prescription of Major Psychotropic Medications and Violent Reoffending After Prison Release.The costs and benefits of diagnosis of ADHD: commentary on Holden et al Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study.Family income in early childhood and subsequent attention deficit/hyperactivity disorder: a quasi-experimental study.Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes.Enhancing ADHD medication adherence: challenges and opportunities The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD.

P2860

Q21131827-311D374D-29C8-465D-ABCB-A51565C6FAAC Q22241098-F6521177-0FC7-42A5-B0D8-798AEE452CCF Q26773188-31FBB686-700B-4E6D-BA8A-24A410345B5E Q26849359-B34318EC-F758-4DBD-9222-E95509F3D7BB Q26849765-D48652A8-62D1-48B0-ABE4-59A83C84D2FF Q26851607-DEDD43E3-3A22-4DA9-A1CD-9E03082E218C Q27027395-FDD53C04-62D9-4E90-8803-76B1339082EB Q28267079-375B479F-9203-42AA-AB55-D22E8605237B Q28548023-A4838CE7-623E-4648-BB1A-9BEEFB954A4F Q28646213-0EEACBB6-0EFC-42A5-BB16-F98A1BBDBC83 Q29353662-E17B0191-1C32-4AB9-A24D-B50CB39E3A9F Q30490016-60DAA476-E438-4E06-899A-61F21CE9786B Q31147482-1B302B0E-C1A7-4851-AFB5-936F8B72ECBC Q33773278-9FDBEDCC-AB26-470E-AB42-8AF07BD441FE Q33829034-E8311A8E-6ED5-40D1-AEA4-0F2A7CE1756C Q33849674-BAF51C00-A3FF-4C84-8B92-CA45579BFB30 Q33919571-CE972696-A7EF-4CD7-B93A-936D30572A9A Q34102167-321E9498-68CA-4362-B053-3F309CF8CD57 Q34194840-D12FA466-C0DF-47E1-AF45-ECDF86D744CB Q34481951-9A7ED475-687D-4D82-8F99-DB7BCEC6AF0E Q34493964-25DCED3E-194D-44EF-B04C-0C20853428D6 Q34505285-2A9F3068-9B04-4164-B371-467ECA18597B Q35005776-94E15393-C5C7-46BE-AC7E-8F9CA17C3E8F Q35776563-0C131D68-6EC3-4211-A1DA-BB26A7C351F2 Q35805186-6E2786C1-CC13-4E9E-BB51-0AA51912D24D Q35936529-79673BFE-F039-4DBC-BE75-2D2990A6AE95 Q36238583-1A61D573-0182-4DD3-BC03-26997DAC82EF Q36259685-9B37A988-EBD0-4938-A10A-10F9E3845249 Q36688215-F75575EE-E71E-4DFD-B2BE-980144AE38B3 Q36761873-77D783B0-6732-43F1-851C-E3F4C2F8B020 Q36925124-BB449371-C916-48D2-A55C-7F0A7005661D Q37300928-FA29F1F6-59BF-4CB4-B26E-39FEEF2AA0CD Q37363571-B12758FF-3BA2-4155-B743-CC395B64EC81 Q37401454-61713B45-CC93-4621-B6C5-05DF75D6491F Q37615841-324021F6-F9E3-4052-B40A-4D1728E8BF34 Q37629463-2028E528-C56B-48C3-82FB-6FDDD897E3B8 Q37656535-FFF1D258-727E-4F1A-BD13-1E2302F4FF4C Q37722786-A45E3E4D-0265-4D11-8BDF-B89E96226802 Q38109853-8C90402C-C918-46AC-9F31-78E35C40C74F Q38140019-4BFCAE4C-297C-40C1-B484-F4A064F55E3B

P2860

Medication for attention deficit-hyperactivity disorder and criminality

http://www.wikidata.org/entity/Q24619697

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Medication for attention deficit-hyperactivity disorder and criminality

@ast

Medication for attention deficit-hyperactivity disorder and criminality

@en

Medication for attention deficit-hyperactivity disorder and criminality

@nl

type

label

Medication for attention deficit-hyperactivity disorder and criminality

@ast

Medication for attention deficit-hyperactivity disorder and criminality

@en

Medication for attention deficit-hyperactivity disorder and criminality

@nl

prefLabel

Medication for attention deficit-hyperactivity disorder and criminality

@ast

Medication for attention deficit-hyperactivity disorder and criminality

@en

Medication for attention deficit-hyperactivity disorder and criminality

@nl

P1433

Q24619697-8B6F3D80-98D2-4F3F-94E8-13982839A63D

P1476

Q24619697-E61D3BC0-B916-441E-AF94-115C0A6B5857

P2093

Q24619697-030A393A-4A3D-44FB-B46F-086A8360E89F

Q24619697-315D4598-5080-4B12-A9BA-968177CF850A

Q24619697-4BC3CF4C-80A0-43FF-A2F5-E8B3E9440C35

P2860

Q24619697-040AD8BE-2B5C-4839-835A-38B973403ED3

Q24619697-138880E2-A75E-45F4-B0BA-C3FB49921E78

Q24619697-1A7A3D7A-D2CA-46E5-8F5D-7224E9F58BDB

Q24619697-1AA37A5C-9403-4FA3-B1EB-7F8685FB776A

Q24619697-1BA3AC3F-D6E6-4F24-8899-54B84BD1198D

Q24619697-30273E24-6450-4F7B-A911-206756239F7B

Q24619697-316000AB-6B96-4737-89E9-08D8320E0D03

Q24619697-3D0362C9-2322-4388-9B98-3C88217F62A2

Q24619697-452AB910-5C75-46AB-9BBF-7C373561D4D1

Q24619697-45F6DE9A-C4BB-47EA-80BC-7EEC8F25FA37

P304

Q24619697-D1953E6B-A337-44D1-9DE1-A0DEFA406628

P31

Q24619697-76EC6653-004B-47B4-BE67-E2D5A4ED8C6A

P3181

Q24619697-A03E06F3-CB08-494B-9569-AD07D5A67DA7

P356

Q24619697-916249C3-3B98-4311-A326-4183BED41AD3

P407

Q24619697-0F13CD47-70F8-404B-8E41-F51B4C1A04DE

P433

Q24619697-175A1CA7-C16C-4FD4-A3BB-DFC9801C98B8

P478

Q24619697-81EC18F8-E498-4E77-891D-7AC3498017A7

P50

Q24619697-41DC3772-2F41-4E30-AA8E-9FDE7121F15A

Q24619697-77175106-3DEE-415C-8CB6-F9DE7A9DDE0A

Q24619697-A276D728-36A0-4E20-8119-A46C1A503ED6

Q24619697-ACABB4DA-F729-4E04-B863-BF3B28BA351D

Q24619697-BA7B84FA-809A-45F0-B81D-2408F1121DEF

P577

Q24619697-78A84ACF-EEF9-45F6-8D9A-3E33AAD6491B

P698

Q24619697-BFC49D77-6ABD-4BFB-99DA-A296DD014F09

P921

Q24619697-AB2CAAE1-8B3A-4F2E-9922-FCD9C407469A

Q24619697-F26695DD-6602-4E9E-AEAA-E3D5F16A51AB

P932

Q24619697-2FA9F548-AED8-47D6-BA73-281DF04AF680

P3181

P356

P1433

The New England Journal of Medicine

P1476

Medication for attention deficit-hyperactivity disorder and criminality

@en

P2093

Arvid Sjölander

http://www.w3.org/2001/XMLSchema#string

Johan Zetterqvist

http://www.w3.org/2001/XMLSchema#string

Niklas Långström

http://www.w3.org/2001/XMLSchema#string

P2860

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

3-Year Follow-up of the NIMH MTA Study

Beyond polemics: science and ethics of ADHD

The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research

Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD

The worldwide prevalence of ADHD: a systematic review and metaregression analysis

Post-approval drug safety surveillance.

How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD

P304

2006-2014

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1421341

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA1203241

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

367

http://www.w3.org/2001/XMLSchema#string

P50

Paul Lichtenstein

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23171097

http://www.w3.org/2001/XMLSchema#string

P921

attention deficit hyperactivity disorder

P932

3664186

http://www.w3.org/2001/XMLSchema#string